Skip to content

Clinical trials

Completed Macular Degeneration trials in Slovakia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Macular Degeneration Status: Completed Country / region: Slovakia Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20111
20133
20151
20191
20202
20211
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer3
Novartis Pharmaceuticals2
Alvotech Swiss AG1
Amgen1
Novartis Slovakia, s.r.o.1
Pfizer1
Sam Chun Dang Pharm. Co. Ltd.1
Shanghai Henlius Biotech1
Sylentis, S.A.1
Xbrane Biopharma AB1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Macular Degeneration13
Blindness1
Choroidal Neovascularization1
Eye Diseases1
Macular Edema1
Retinal Degeneration1
Retinal Diseases1
Retinal Vein Occlusion1
Vision Disorders1
Wet Macular Degeneration1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.